IGFBP7 and COVID-19: More studies should be carried out to investigate the effect of [TIMP-2] • [IGFBP7] in predicting AKI and the progress of the disease and determine its clinical usage in the phenotyping of clinical AKI in patients with COVID-19 (Table 1).